Yoshida Y - Search Results

1

Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.

Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kurokawa T, Kobayashi M, Tsuchida T, Fujibayashi Y, Kotsuji F, Okazawa H. Tsujikawa T, et al. Among authors: yoshida y. J Nucl Med. 2009 Oct;50(10):1598-604. doi: 10.2967/jnumed.108.060145. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759112 Free article. Clinical Trial.

2

Characteristics of lung cancer in the elderly.

Mizushima Y, Kashii T, Yoshida Y, Sugiyama S, Kobayashi M. Mizushima Y, et al. Among authors: yoshida y. Anticancer Res. 1996 Sep-Oct;16(5B):3181-4. Anticancer Res. 1996. PMID: 8920787

3

Establishment of a liver metastatic model of human ovarian cancer.

Yoshida Y, Kamitani N, Sasaki H, Kusumi K, Tominaga T, Kotsuji F. Yoshida Y, et al. Anticancer Res. 1998 Jan-Feb;18(1A):327-31. Anticancer Res. 1998. PMID: 9568098

4

Establishment of a cell line from a neuroendocrine carcinoma of the endometrium and an invasion model.

Yoshida Y, Kamitani N, Sasaki H, Kotsuji F. Yoshida Y, et al. Anticancer Res. 1998 May-Jun;18(3A):1569-77. Anticancer Res. 1998. PMID: 9673372

5

Superficial blood flow, blood volume, and blood velocity in colorectal tubular adenomas and adenocarcinomas.

Fujimori S, Kishida T, Yoshida Y, Kobayashi M. Fujimori S, et al. Among authors: yoshida y. J Gastroenterol. 1999 Aug;34(4):467-73. doi: 10.1007/s005350050298. J Gastroenterol. 1999. PMID: 10452679

6

Markers of apoptosis and angiogenesis indicate that carcinomatous components play an important role in the malignant behavior of uterine carcinosarcoma.

Yoshida Y, Kurokawa T, Fukuno N, Nishikawa Y, Kamitani N, Kotsuji F. Yoshida Y, et al. Hum Pathol. 2000 Dec;31(12):1448-54. doi: 10.1053/hupa.2000.20372. Hum Pathol. 2000. PMID: 11150369

7

Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range.

Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Fujibayashi Y, Yonekura Y, Kotsuji F. Kurokawa T, et al. Among authors: yoshida y. Ann Nucl Med. 2002 Nov;16(7):491-3. doi: 10.1007/BF02988649. Ann Nucl Med. 2002. PMID: 12508842

8

A phase I study of continuous administration of 5-fluorouracil/cisplatin in advanced uterine cervical cancer.

Yoshida Y, Goto K, Kawahara K, Kurokawa T, Shukunami K, Kotsuji F. Yoshida Y, et al. Anticancer Res. 2002 Nov-Dec;22(6B):3473-6. Anticancer Res. 2002. PMID: 12552941 Clinical Trial.

9

Establishment of a novel human ovarian cancer cell line with high anchorage-independent growth ability.

Nishikawa Y, Yoshida Y, Kawahara K, Kurokawa T, Tajima K, Kotsuji F. Nishikawa Y, et al. Among authors: yoshida y. Int J Oncol. 2003 Dec;23(6):1679-86. doi: 10.3892/ijo.23.6.1679. Int J Oncol. 2003. PMID: 14612941

10

Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer.

Yoshida Y, Kurokawa T, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F. Yoshida Y, et al. AJR Am J Roentgenol. 2004 Jan;182(1):227-33. doi: 10.2214/ajr.182.1.1820227. AJR Am J Roentgenol. 2004. PMID: 14684544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,016 results

Search Page

Filters